COVID-19 UPDATE: All elective surgeries and procedures are cancelled until further notice. Please see our latest visitor policy. If you think you may have been exposed or have symptoms, please call your provider before visiting one of our locations. For more information, please visit our online COVID-19 Information Center or call the Montefiore-Einstein COVID-19 Hotline: 1-844-444-CV19 (1-844-444-2819).

ACTUALIZACIÓN SOBRE EL COVID-19: Todas las cirugías y operaciones quedan canceladas hasta nuevo aviso. Lea nuestras nuevas normas para visitas. Si cree que podría haber estado en contacto con la enfermedad o si presenta síntomas, por favor llame a su proveedor antes de acudir a cualquiera de nuestros centros. Más información en nuestro Centro de Información en Línea sobre el COVID-19 o llamando a la línea informativa Montefiore-Einstein de COVID-19: 1-844-444-CV19 (1-844-444-2819).


Abdominal Imaging Publications

LI-RADS 2017: An Update
Kielar AZ; Chernyak V; Bashir MR; Do RK; Fowler KJ; Mitchell DG; Cerny M; Elsayes KM; Santillan C; Kamaya A; Kono Y; Sirlin CB; Tang A.

Practical Guide to Dynamic Pelvic Floor MRI
Kobi M; Flusberg M; Paroder V; Chernyak V.

CT Colonography: Over Two Decades From Discovery to Practice
Pickhardt PJ; Yee J; Johnson CD.

Extracolonic Findings and Radiation at CT Colonography: What the Referring Provider Needs to Know
Yee J; McFarland E.

Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features
Chernyak V; Flusberg M; Law A; Kobi M; Paroder V; Rozenblit AM.

Epidemiology of Hepatocellular Carcinoma: Target Population for Surveillance and Diagnosis
Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB.

LI-RADS® Algorithm: CT and MRI
Chernyak V; Santillan CS; Papadatos D; Sirlin CB.

LI-RADS® Ancillary Features on CT and MRI
Chernyak V; Tang A; Flusberg M; Papadatos D; Bijan B; Kono Y; Santillan C.

LI-RADS Categories: Concepts, Definitions, and Criteria
Santillan C;, Chernyak V; Sirlin C.

LI-RADS Major Features: CT, MRI with Extracellular Agents, and MRI with Hepatobiliary Agents
Santillan C; Fowler K; Kono Y; Chernyak V.

LI-RADS and Transplantation for Hepatocellular Carcinoma
Tang A; Fowler KJ; Chernyak V; Chapman WC; Sirlin CB.

Locoregional Therapies for Hepatocellular Carcinoma and the New LI-RADS Treatment Response Algorithm
Kielar A; Fowler KJ; Lewis S; Yaghmai V; Miller FH; Yarmohammadi H; Kim C; Chernyak V; Yokoo T; Meyer J; Newton I; Do RK.

Renal Vein Tumor Thrombus From Metastatic Anal Gland Adenocarcinoma
Ari Bernstein; Judy Sarungbam; Victoria Chernyak; Lakshmi Rajdev; Evan Kovac.

2017 Version of LI-RADS for CT and MR Imaging: An Update
Elsayes KM; Hooker JC; Agrons MM; Kielar AZ; Tang A; Fowler KJ; Chernyak V; Bashir MR; Kono Y; Do RK; Mitchell DG; Kamaya A; Hecht EM; Sirlin CB.

ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma
Qayyum A; Tamm EP; Kamel IR; Allen PJ; Arif-Tiwari H; Chernyak V; Gonda TA; Grajo JR; Hindman NM; Horowitz JM; Kaur H; McNamara MM; Noto RB; Srivastava PK; Lalani T.

Identifying Intestinal Malrotation on Magnetic Resonance Examinations Ordered for Unrelated Indications
Fay JS; Chernyak V; Taragin BH.

Advances in Imaging in Prostate and Bladder Cancer
Srivastava A; Douglass LM; Chernyak V; Watts KL.

Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis
Flusberg M; Ganeles J; Ekinci T; Goldberg-Stein S; Paroder V; Kobi M; Chernyak V.

Effect of Threshold Growth as a Major Feature on LI-RADS Categorization
Chernyak V; Kobi M; Flusberg M; Fruitman KC; Sirlin CB.